Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Product Stability01:16

Drug Product Stability

218
The long-term stability of drug products is critical to ensuring their quality, safety, and effectiveness over time. Stability directly influences a product's ability to maintain its intended characteristics, ensuring it performs as expected during its intended shelf life. Key attributes such as drug potency, impurities, dissolution, and other physicochemical measures of performance are tested to assess stability. These parameters indicate how well the product retains its quality over time and...
218
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention01:05

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

185
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
185
Vaccinations01:51

Vaccinations

51.2K
Overview
51.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictive modeling of immune escape and antigenic grouping of SARS-CoV-2 variants.

Journal of virology·2026
Same author

Protective immunity against malaria by a nanoparticle CIS43-based junctional vaccine alone or in combination with R21.

NPJ vaccines·2026
Same author

Multiple Measles Transmission Events Associated with a Single Traveler Arriving in the United States, May 2025.

The Journal of infectious diseases·2026
Same author

Vaccine elicitation of HIV-1 neutralizing antibodies against both V2 apex and fusion peptide in rhesus macaques.

Cell reports·2026
Same author

Demonstration of <i>in vivo</i> efficacy, cryo-EM-epitope identification, and breadth of two anti-alphavirus bispecific single domain antibodies.

Journal of virology·2025
Same author

COVID-19 pandemic and waning immunity disrupted measles population immunity and strategies to close immunity gaps.

Nature communications·2025
Same journal

Somatosensory cortex shapes perceptual decision bias via the superior colliculus.

Research square·2026
Same journal

Combinatorial Targeting of Avapritinib-Driven MAP Kinase Activation in High-Grade Glioma.

Research square·2026
Same journal

Supporting Implementation of the National Standards for Cancer Survivorship Care: Development of the Cancer Survivorship Maturity Model (CSMM).

Research square·2026
Same journal

Operationalizing a walking exercise prescription based on 6-minute walk test results.

Research square·2026
Same journal

Age but not sex modifies lymphoid immune responses in murine sepsis.

Research square·2026
Same journal

Indirect effect, through aspects of neighborhood affluence and racial/ethnic composition, of receiving a Section 8 voucher on the prevalence of psychiatric disorders among boys and girls in the Moving to Opportunity study.

Research square·2026
See all related articles

Related Experiment Video

Updated: Jan 11, 2026

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
13:53

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Published on: December 19, 2020

5.4K

A Computationally Optimised Structural Integrity Sequence Enhances Vaccine Stability, Yield and Safety Profile.

Arthur Sarron1, Sun B Sowers2, Yaroslav Tsybovsky3

  • 1Queen's University Belfast.

Research Square
|November 19, 2025
PubMed
Summary
This summary is machine-generated.

A new computational pipeline, VaCRiSta, enhances vaccine safety by reducing autoimmune risks. This method optimizes vaccine candidates, improving stability, expression, and immune response, as demonstrated with a mumps vaccine candidate.

More Related Videos

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

5.0K
A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

3.0K

Related Experiment Videos

Last Updated: Jan 11, 2026

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
13:53

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Published on: December 19, 2020

5.4K
Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

5.0K
A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

3.0K

Area of Science:

  • Vaccinology
  • Computational Biology
  • Immunology

Background:

  • Recombinant vaccines are vital for global health, but potential autoimmune reactions from molecular mimicry pose a safety concern.
  • Sequence similarity between vaccine antigens and human proteins can theoretically trigger adverse immune responses.

Purpose of the Study:

  • To introduce the Vaccine Candidate de-Risking and Stabilisation (VaCRiSta) computational pipeline for enhancing vaccine safety and stability.
  • To apply VaCRiSta to a mumps vaccine candidate to assess its de-risking and stabilizing capabilities.

Main Methods:

  • Integrated sequence similarity searches, epitope prediction, homology modeling, and molecular dynamics simulations.
  • Applied the VaCRiSta pipeline to the GCN4 trimerization domain in the context of the mumps F protein.
  • Utilized negative-stain electron microscopy for structural integrity confirmation.

Main Results:

  • The optimized GCN4_QM sequence significantly reduced human proteome matches, mitigating potential autoimmune risks.
  • GCN4_QM enhanced the stability of the trimeric F protein assembly and doubled protein expression yield (2.2 vs. 1.1 mg/L).
  • The modified protein maintained structural integrity and elicited approximately 3-fold higher neutralizing antibody titers in mice.

Conclusions:

  • The VaCRiSta approach effectively de-risks and stabilizes vaccine candidates, improving safety, yield, and immunogenicity.
  • GCN4_QM serves as a valuable structural module for protein engineering and multimeric vaccine design, enhancing solubility.
  • This computational strategy holds potential for improving vaccine efficacy and delivery to populations worldwide.